Access the full text.
Sign up today, get DeepDyve free for 14 days.
M.T. Moody, M.M. Ringel, C.M. Mathews, K.M. Midthun (2022)
Determination of cross-reactivity of contemporary cannabinoids with THC direct immunoassay (ELISA) in whole blood, 46
M. Tagen, L.E. Klumpers (2022)
Review of delta-8-tetrahydrocannibnol (Δ8-THC): comparative pharmacology with THC, 179
J.M. Holler, M.L. Smith, S.N. Paul, M.R. Past, B.D. Paul (2008)
Isomerization of delta-9-THC to delta-8-THC when tested as trifluoroacetyl- pentafluoropropionyl- or heptafluorobutyryl- derivatives, 43
(2022)
THC Forensic ELISA Kit (Item No. 131019) Package Insert
E.C. Leas, A.L. Nobles, Y. Shi, E. Hendrickson (2022)
Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use, 101
E.C. Leas (2021)
The hemp loophole: a need to clarify the legality of delta-8-THC and other hemp-derived tetrahydrocannabinol compounds, editorial, 111
(2018)
Agriculture Improvement Act of 2018 (2018 Farm Act), One Hundred Fifteenth Congress of the United States of America
A. Chan-Hosokawa, L. Nguyen, N. Lattanzio, W.R. Adams (2022)
Emergence of delta-8 tetrahydrocannabinol in DUID investigation casework: method development, validation and application, 46
T. Boos (2021)
Drug Enforcement Agency (DEA) Response on Delta-8-Tetrahydrocannabinol to the Alabama Board of Pharmacy (ALBOP) {Letter}
M.A. ElSohly, A.B. Jones, H.N. ElSohly (1990)
Cross-reactivity of selected compounds in the Abbott TDx® cannabinoid assay, 14
S. Rzeppa, J. Große, C. Rautenberg, D. Thieme, T. Lepp, H. Vallimae (2021)
Emergence of the less common cannabinoid Δ8- tetrahydrocannabinol in a doping sample, 13
G.R.B. Webster, L.P. Sarna, R. Mechoulam (2004)
Conversion of CBD to delta8-THC and delta9-THC
J.D. Reber, E.L. Karschner, J.Z. Seither, J.L. Knittel, K.V. Dozier, J.P. Walterscheid (2022)
An enhanced LC-MS-MS technique for distinguishing Δ8- and Δ9-tetrahydrocannabinol isomers in blood and urine specimens, 46
A. Helander, M. Johansson, A. Andersson, T. Villen (2022)
Analytical and medico-legal problems linked to the presence of delta-8-tetrahydrocannabinol (delta-8-THC): results from urine drug testing in Sweden, 14
D. Hart (2019)
National Laboratory Certification Program Drug Testing Matters, Cannabinoid Metabolites Pose Analytical Challenges in Urine Drug Testing Laboratories
(2019)
CEDIA-Multi-Level-THC Assay Package Insert
(2022)
Controlled Substances—Alphabetical Order
J.S. Kruger, D.J. Kruger (2022)
Delta-8-THC: delta-9-THC’s nicer younger sibling?, 4
Laws concerning the growing, selling and consuming of cannabis and its related products have been changing considerably over the last few years. The legalization of hemp in 2018 sparked an interest in ∆9-tetrahydrocannabinol (∆9-THC) isomers and analogs that are derived from hemp and sold with minimal oversight. One example is ∆8-tetrahydrocannabinol (∆8-THC). Although less potent than ∆9-THC, ∆8-THC is gaining popularity and can easily be found where cannabis-related products are sold. The Forensic Toxicology Laboratory at the University of Florida routinely tested decedents for 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid (∆9-THC-acid), the primary metabolite of ∆9-THC. Urine samples from ∼900 decedents were received by the laboratory between mid-November 2021 and mid-March 2022 and subjected to CEDIA™ immunoassay testing. Subsequent confirmation of 194 presumptive positive samples was performed by gas chromatography--mass spectrometry. A peak eluting immediately after ∆9-THC-acid was identified as 11-nor-∆8-tetrahydrocannabinol-9-carboxylic acid (∆8-THC-acid), a metabolite of ∆8-THC, in 26 of those samples (13%). Six of the samples were positive for ∆8-THC-acid only. Other toxicological findings were consistent with poly-drug use including fentanyl/fentanyl analogs, ethanol, cocaine and methamphetamine. There has been an emergence of ∆8-THC use as indicated by the presence of ∆8-THC-acid in 26 of 194 presumptive positive cases during a four-month period. The majority of individuals were White males with a history of drug and/or alcohol use. ∆9-THC-acid, as well as other drugs, was often present. Given the psychoactive potential and availability of ∆8-THC, monitoring ∆8-THC-acid in decedents is important to characterize the risk and prevalence of ∆8-THC use.
Journal of Analytical Toxicology – Oxford University Press
Published: Apr 7, 2023
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.